Biolase (BIOL) Receives News Sentiment Rating of 0.20
Media headlines about Biolase (NASDAQ:BIOL) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a …